Healthcare AI implementation and ROI evaluation

The healthcare industry is navigating a transition in how artificial intelligence is implemented and evaluated. Initial research highlights a widening gap between the rapid scaling of AI technologies and the ability of organizations to demonstrate a clear financial return on investment (ROI). While many leaders are expanding AI capabilities, only 18% of those scaling the technology report having mature financial attribution tools to link spending to measurable outcomes.

As the sector moves forward, the focus is shifting from technical experimentation with ambient AI toward evaluating its real-world impact on clinical workflows and patient care. Experts suggest that measuring value must move beyond simple activity metrics, such as minutes saved, to focus on completed work and meaningful outcomes.

Recent corporate developments reflect this scaling trend. Australian startup Heidi Health secured $340 million in new funding, bringing its valuation to $900 million. The company plans to use the capital to expand its ‘AI Care Partner’ capabilities, transitioning from its core AI scribe function toward providing supervised agentic tools for clinicians. As part of a North American expansion, Heidi is investing $25.4 million CAD to establish a headquarters in Toronto, Canada. This growth follows a significant rise in the company’s annual recurring revenue, which grew from $1 million to $50 million over two years. Despite such capital inflows, industry discussions continue to emphasize that successful implementation must deliver measurable clinical, operational, and financial value through completed workflows rather than mere task automation.